EURECA
Enabling information re-Use by linking clinical REsearch and CAre
| Coordinatore | PHILIPS ELECTRONICS NEDERLAND B.V.
Organization address
address: High Tech Campus 34 contact info |
| Nazionalità Coordinatore | Netherlands [NL] |
| Totale costo | 13˙403˙166 € |
| EC contributo | 9˙651˙000 € |
| Programma | FP7-ICT
Specific Programme "Cooperation": Information and communication technologies |
| Code Call | FP7-ICT-2011-7 |
| Funding Scheme | CP |
| Anno di inizio | 2012 |
| Periodo (anno-mese-giorno) | 2012-02-01 - 2015-07-31 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
PHILIPS ELECTRONICS NEDERLAND B.V.
Organization address
address: High Tech Campus 34 contact info |
NL (Eindhoven) | coordinator | 0.00 |
| 2 |
BREAST INTERNATIONAL GROUP - AISBL
Organization address
address: BOULEVARD DE WATERLOO 121 contact info |
BE (BRUXELLES) | participant | 0.00 |
| 3 |
CUSTODIX NV
Organization address
address: KORTRIJKSESTEENWEG 214 b3 contact info |
BE (SINT-MARTENS-LATEM) | participant | 0.00 |
| 4 |
ecancermedicalscience AG
Organization address
address: c/o Bruno Wanner Management, Gotthardstrasse 20 contact info |
CH (Zug) | participant | 0.00 |
| 5 |
EUROPEAN INSTITUTE FOR HEALTH RECORDS
Organization address
address: RUE DU MARECHAL DE LATTRE DE TASSIGNY 8 contact info |
FR (LILLE) | participant | 0.00 |
| 6 |
FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLAS
Organization address
address: N PLASTIRA STR 100 contact info |
EL (HERAKLION) | participant | 0.00 |
| 7 |
FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V
Organization address
address: HANSASTRASSE 27C contact info |
DE (MUNCHEN) | participant | 0.00 |
| 8 |
GBG FORSCHUNGS GMBH
Organization address
address: MARTIN BEHAIM STRASSE 12 contact info |
DE (NEU-ISENBURG) | participant | 0.00 |
| 9 |
GOTTFRIED WILHELM LEIBNIZ UNIVERSITAET HANNOVER
Organization address
address: Welfengarten 1 contact info |
DE (HANNOVER) | participant | 0.00 |
| 10 |
Institut Jules Bordet
Organization address
city: Brussels contact info |
BE (Brussels) | participant | 0.00 |
| 11 |
NATIONAL RESEARCH COUNCIL CANADA
Organization address
address: Montreal Road 1200 contact info |
CA (Ottawa, ON) | participant | 0.00 |
| 12 |
STICHTING MAASTRICHT RADIATION ONCOLOGY MAASTRO CLINIC
Organization address
address: Dr. Tanslaan 12 contact info |
NL (Maastricht) | participant | 0.00 |
| 13 |
STICHTING VU-VUMC
Organization address
address: DE BOELELAAN 1105 contact info |
NL (AMSTERDAM) | participant | 0.00 |
| 14 |
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
Organization address
address: University Offices, Wellington Square contact info |
UK (OXFORD) | participant | 0.00 |
| 15 |
UNIVERSIDAD POLITECNICA DE MADRID
Organization address
address: CALLE RAMIRO DE MAEZTU 7 EDIFICIO RECTORADO contact info |
ES (MADRID) | participant | 0.00 |
| 16 |
UNIVERSITAET DES SAARLANDES
Organization address
address: . contact info |
DE (SAARBRUCKEN) | participant | 0.00 |
| 17 |
XEROX SAS
Organization address
address: Avenue du President Wilson, Immeuble Le Jade 253/255 contact info |
FR (SAINT-DENIS) | participant | 0.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
EURECA aims to build an advanced, standards-based and scalable semantic integration environment enabling seamless, secure and consistent bi-directional linking of clinical research and clinical care systems to: 1.Support more effective and efficient execution of clinical research by Allowing faster eligible patient identification and enrolment in clinical trials, Providing access to the large amounts of patient data, Enabling long term follow up of patients, Avoid the current need for multiple data entry in the various clinical care. 2.)Allow data mining of longitudinal EHR data for early detection of patient safety issues related to therapies and drugs that would not become manifest in a clinical trial either due to limited sample size or to limited trial duration, 3:)Allow for faster transfer of new research findings and guidelines to the clinical setting (from bench-to-bedside), 4.) Enable healthcare professionals to extract in each patient's case the relevant data out of the overwhelmingly large amounts of heterogeneous patient data and treatment information. At the core of the project will be achieving semantic interoperability among EHR and clinical trial systems, consistent with existing standards, while managing the various sources of heterogeneity: technology, medical vocabulary, language, etc. This requires the definition of sound information models describing the EHR and the clinical trial systems, and capturing the semantics of the clinical terms by standard terminology systems. The scalability of the solution will be achieved by modularization, identifying core data subsets covering the chosen clinical domains. We demonstrate and validate concepts developed in EURECA by implementing a set of software services and tools that we deploy in the context of pilot demonstrators. EURECA will develop solutions that fulfill the data protection and security needs and the legal, ethical and regulatory requirements related to linking research and EHR data.